Skip to content
Screener

Personalis, Inc. PSNL Investing Cash Flow

Investing Cash Flow at other companies

Quest Diagnostics logo
Quest DiagnosticsDGX
-$134M-8.1%
NeoGenomics logo
NeoGenomicsNEO
-$8.32M+10.7%
Illumina logo
IlluminaILMN
-$121M-147%
Veracyte logo
VeracyteVCYT
-$127.96M-147%
Biodesix, Inc. logo
Biodesix, Inc.BDSX
-$254K-167%
Guardant Health logo
Guardant HealthGH
$699.42M+131%

Other financials

Income statement

See full
Revenue$15.5M-24.9%
Gross profit$281.0K-96.1%
Operating income-$32.2M-81.7%
Net income-$30.0M-90.7%
EPS (diluted)-$0.29-61.1%

Balance sheet

See full
Cash & equivalents$73.6M+3.7%
Total debt$39.0M-6.2%
Total equity$254.8M+22.9%
Total assets$325.4M+19.1%

Cash flow

See full
Operating cash flow-$22.5M-25.1%
CapEx$3.2M+27.1%
Free cash flow-$25.7M-25.4%

Valuation

See full
Market cap$1.51B+279%
Enterprise value$1.48B+283%
P/S23.4×+18.5×

Profitability

See full
Gross margin13.7%-19.6pp
Operating margin-158.9%-5,457pp
Net margin-148.1%+154pp
FCF margin-131.2%-453pp

Returns & leverage

See full
Return on equity-41.4%-6.7pp
Debt / equity0.2×0.0×
Current ratio6.6×-0.3×

Where this comes from

Reported directly by Personalis, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The source filing: Personalis, Inc.’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:10 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-211896
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Proceeds from maturities of available-for-sale debt securities24,10044,250
Purchases of property and equipment(3,192)(2,511)
Proceeds from sales of property and equipment (4)120
Net cash used in investing activities(46,012)(22,542)
Cash flows from financing activities:
Proceeds from sales of common stock under ATM facility, net of commissions20,95217,782
Payment of costs related to Tempus and Merck Investment Agreements(106)
Proceeds from loans2,587

Item 1. Financial Statements

FAQ

What is Personalis, Inc.'s investing cash flow?
Personalis, Inc. (PSNL) reported investing cash flow of -$46.01M in Q1 2026.
How has Personalis, Inc.'s investing cash flow changed year-over-year?
Personalis, Inc.'s investing cash flow decreased by 104.1% year-over-year, from -$22.54M to -$46.01M.
What does investing cash flow mean?
Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Ask your AI about Personalis, Inc.'s investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude